MR VACCINES MARKET ANALYSIS

MR Vaccines Market, by Vaccine Brand (MR Vaccine and MRBEV (BE LTD.), by Distribution Channel (Private and Public), and by Region (Commonwealth of Independent States (CIS) Countries, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Feb 2022
Code : CMI4917
Pages :154
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

MR Vaccines Market Restraint

The risk of adverse reactions associated with measles and rubella (MR) vaccines are expected to hinder the growth of the MR vaccines market over the forecast period.

For instance, according to a report published by the U.S. National Library of Medicine in January 2021, adverse reactions related to Measles and Rubella vaccination are fever, followed by vomiting, abdominal pain, and dizziness. After 4-5 days of MR vaccine administration, few children may have abnormal body movements. In few cases, altered sensorium was detected on the same day as vaccine delivery.

Mr Vaccines Market Restraints & Challenges:

Risk of adverse reactions associated with measles and rubella (MR) vaccines
Increasing research and development activities and ongoing clinical trials for the development of safe MR vaccines
Rising government initiatives to launch vaccine campaigns